New SEC Form D filing

BioGene Therapeutics Inc., 2026-08-06

A new SEC Form D private-offering notice from Austin, TX, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

BioGene Therapeutics Inc. site↗ Verified via SEC Form D

Develops gene therapy and lipid nanoparticle delivery technology targeting metabolic disorders such as diabetes and obesity.

Filed 2026-08-06Filed to raise $3,000,000First money in 2026-03-10Raised so far $3,000,000HQ (as filed) Austin, TXSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified biogenetherapeutics.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Also filed for this raise

every source Form D behind this opportunity
  • BioGene Therapeutics Inc., 2026-08-06, $250K EDGAR↗
  • BioGene Therapeutics Inc., 2026-08-06, $3M EDGAR↗

Other Form D filings from the same week

each with its own page and its own EDGAR source